604
Views
6
CrossRef citations to date
0
Altmetric
Pharmacotherapy

Efficacy and safety of the combination fluticasone propionate plus salmeterol in asthmatic preschoolers: An observational study

, , , , , , , MD, ORCID Icon & show all
Pages 573-580 | Received 31 Oct 2017, Accepted 06 May 2018, Published online: 29 Jun 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Hacer Ilbilge Ertoy Karagol & Arzu Bakirtas. (2021) New Perspectives in the Management of Mild to Moderate Asthma in Children. Journal of Asthma and Allergy 14, pages 293-299.
Read now

Articles from other publishers (5)

Hua Li, Tao Dong & Jinling Luan. (2024) Efficacy and safety of fluticasone propionate/salmeterol and fluticasone propionate monotherapy in step-up treatment of childhood asthma: A systematic review and meta-analysis. Heart & Lung 63, pages 23-34.
Crossref
Hai Lee Chung. (2022) Diagnosis and management of asthma in infants and preschoolers. Clinical and Experimental Pediatrics 65:12, pages 574-584.
Crossref
阳 李. (2022) Meta-Analysis of Seretide Combined with Suhuang Zhike Capsule in the Treatment of Cough Variant Asthma. Advances in Clinical Medicine 12:05, pages 3994-4004.
Crossref
Sheersha Pramanik, Sourav Mohanto, Ravi Manne, Rahul R. Rajendran, A. Deepak, Sijo Joy Edapully, Triveni Patil & Oly Katari. (2021) Nanoparticle-Based Drug Delivery System: The Magic Bullet for the Treatment of Chronic Pulmonary Diseases. Molecular Pharmaceutics 18:10, pages 3671-3718.
Crossref
Shigemi Yoshihara, Toshikazu Tsubaki, Masanori Ikeda, Warren Lenney, Richard Tomiak, Takako Hattori, Kenichi Hashimoto, Toru Soutome & Shihona Kato. (2019) The efficacy and safety of fluticasone/salmeterol compared to fluticasone in children younger than four years of age. Pediatric Allergy and Immunology 30:2, pages 195-203.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.